At his blog Epidemix, Thomas Goetz makes a case against California and New York’s cease-and-desist letters to personal genomics companies by saying that this will harm the public's health. He says that the small subset of individuals who might overreact to the tests is far outnumbered by those who will use the information wisely.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.